Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

ProQR Therapeutics (PRQR) Return on Capital Employed (2016 - 2023)

ProQR Therapeutics' Return on Capital Employed history spans 3 years, with the latest figure at 30.05% for Q4 2023.

  • On a quarterly basis, Return on Capital Employed rose 2391.0% to 30.05% in Q4 2023 year-over-year; TTM through Dec 2023 was 30.05%, a 2391.0% increase, with the full-year FY2025 number at 43.0%, down 1639.0% from a year prior.
  • Return on Capital Employed hit 30.05% in Q4 2023 for ProQR Therapeutics, up from 31.37% in the prior quarter.
  • Over the last five years, Return on Capital Employed for PRQR hit a ceiling of 30.05% in Q4 2023 and a floor of 58.47% in Q3 2022.
  • Historically, Return on Capital Employed has averaged 40.14% across 3 years, with a median of 37.31% in 2023.
  • Biggest five-year swings in Return on Capital Employed: tumbled -2080bps in 2022 and later skyrocketed 2709bps in 2023.
  • Tracing PRQR's Return on Capital Employed over 3 years: stood at 33.17% in 2021, then tumbled by -63bps to 53.96% in 2022, then surged by 44bps to 30.05% in 2023.
  • Business Quant data shows Return on Capital Employed for PRQR at 30.05% in Q4 2023, 31.37% in Q3 2023, and 37.31% in Q2 2023.